IBEX Limited
NASDAQ:IBEX · NASDAQ Global Market
-$0.52 today
Vol 0.23M · Avg 0.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
27.4%
avg 1.9%
ROIC
16.7%
avg 5.5%
ROA
13.5%
avg 3.1%
Analysis
ROE is currently the strongest return metric at 27.4% versus its period average of 1.9%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Robert T. Dechant | Chief Executive Officer & Director | $1.67M | — | 64 | $285,606.00 | 2.13% |
Taylor C. Greenwald | Chief Financial Officer | $928,884.00 | — | 58 | $62,230.00 | 0.46% |
David Afdahl | Chief Operating Officer | $885,838.00 | — | 52 | $157,302.00 | 1.17% |
Bruce N. Dawson | Chief Sales & Client Services Officer | $769,789.00 | — | 62 | $61,895.00 | 0.46% |
Julie Casteel | Chief Marketing & Strategic Accounts Officer | $752,021.00 | — | 64 | $117,594.00 | 0.88% |
Christy O'Connor | Chief Legal Officer & Assistant Corporate Secretary | — | — | 57 | — | — |
Michael Ringman | Chief Technology Officer | — | — | 54 | $41,260.00 | 0.31% |
Carl O'Neil | EVP & President of Augment | — | — | 47 | — | — |
Greg Rajchel | Executive Vice President of Commercial & Client Operations | — | — | — | — | — |
Paul Inson | Chief People Officer | — | — | 62 | $31,469.00 | 0.24% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
38
$5.66M
Net Sentiment
$5.66M
Net selling
Most Active
Dechant Robert Thomas
11 transactions
1–10 of 38
Analysis
Insiders reported 0 buys worth $0.00 and 38 sells worth $5.66M over the last 12 months. That adds up to net selling of $5.66M. Dechant Robert Thomas was the most active insider with 11 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | +32.2% (8yr)1 analysts |
| Revenue | N/A | N/A | +6.6% | +6.2% (8yr)1 analysts |
| Net Income | N/A | N/A | N/A | +30.3% (8yr)1 analysts |
| EBIT | N/A | N/A | N/A | +20.6% (8yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +6.6% over three years. Forward estimates point to EPS at +32.2% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
OneSpan Inc.
NASDAQ:OSPN
$499.00M
Climb Global Solutions, Inc.
NASDAQ:CLMB
$409.70M
Xerox Holdings Corporation
NASDAQ:XRX
$402.19M
TSS, Inc.
NASDAQ:TSSI
$373.35M
Telos Corporation
NASDAQ:TLS
$324.34M
The Hackett Group, Inc.
NASDAQ:HCKT
$256.18M
Conduent Incorporated
NASDAQ:CNDT
$223.34M
Endava plc
NYSE:DAVA
$143.31M
NovaBridge Biosciences
NASDAQ:NBP
$74.17M
LZ Technology Holdings Limited Class B Ordinary Shares
LZMH
$11.23M
Who manages IBEX?
IBEX Limited (IBEX) lists 10 active executives. The top listed executive is Julie Casteel, Chief Marketing & Strategic Accounts Officer.
Are IBEX insiders buying or selling?
Recent insider activity shows net selling of $102.07M.
Explore More
Continue the stock analysis
Jump to another research area for this company.